WIN Consortium WIN 聯合會
WIN 聯合會由得克薩斯大學MD Anderson癌癥中心(美國)和Gustave Roussy研究所(法國)于2010年發起,是學術界、制藥、生物技術、健康保健IT和患者權益領域29家領先組織的全球性網絡,旨在通過世界各地的臨床試驗和研究課題,開發、應用基于基因組的癌癥研究中最具前景的進展,加快抗癌新藥向臨床轉化的步伐、降低成本。WIN是非政府、非營利組織,總部設在巴黎。
Initiated in 2010 by the University of Texas MD Anderson Cancer Center (USA) and the Institut Gustave Roussy (France), the WIN Consortium is a global network of 29 leading organizations from the academic, pharmaceutical, biotechnology, healthcare IT, and patient advocacy sectors working to accelerate the pace and reduce the cost of translating novel cancer treatments to the bedside by developing and applying, through worldwide clinical trials and research projects, the most promising advances in genomic-based cancer research. WIN is a non-governmental, not-for-profit organization headquartered in Paris.